Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 237

1.

Quantitative analysis of survivin mRNA expression in bladder transitional cell carcinomas.

Kitsukawa S, Aoyagi T, Noda K, Ito T, Yamamoto Y, Hosoda S, Otsuru N, Matsumoto T.

Hinyokika Kiyo. 2008 Feb;54(2):101-6.

PMID:
18323166
[PubMed - indexed for MEDLINE]
Free Article
2.

Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.

Karam JA, Lotan Y, Ashfaq R, Sagalowsky AI, Shariat SF.

Urology. 2007 Sep;70(3):482-6.

PMID:
17905101
[PubMed - indexed for MEDLINE]
3.

Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis.

Weikert S, Christoph F, Schrader M, Krause H, Miller K, Müller M.

Int J Cancer. 2005 Aug 10;116(1):100-4.

PMID:
15761870
[PubMed - indexed for MEDLINE]
4.

Detection of survivin mRNA in urine of patients with superficial urothelial cell carcinomas.

Pina-Cabral L, Santos L, Mesquita B, Amaro T, Magalhães S, Criado B.

Clin Transl Oncol. 2007 Nov;9(11):731-6.

PMID:
18055328
[PubMed - indexed for MEDLINE]
5.

The expression and significance of survivin mRNA in urinary bladder carcinomas.

Wang H, Xi X, Kong X, Huang G, Ge G.

J Cancer Res Clin Oncol. 2004 Aug;130(8):487-90. Epub 2004 May 8.

PMID:
15138808
[PubMed - indexed for MEDLINE]
6.

Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma.

Tsui KH, Cheng AJ, Chang Pe, Pan TL, Yung BY.

Urology. 2004 Oct;64(4):839-44.

PMID:
15491744
[PubMed - indexed for MEDLINE]
7.

Survivin expression is associated with bladder cancer presence, stage, progression, and mortality.

Shariat SF, Ashfaq R, Karakiewicz PI, Saeedi O, Sagalowsky AI, Lotan Y.

Cancer. 2007 Mar 15;109(6):1106-13.

PMID:
17311310
[PubMed - indexed for MEDLINE]
Free Article
8.

Survivin mRNA expression is elevated in malignant urothelial cell carcinomas and predicts time to recurrence.

Schultz IJ, Kiemeney LA, Witjes JA, Schalken JA, Willems JL, Swinkels DW, de Kok JB.

Anticancer Res. 2003 Jul-Aug;23(4):3327-31.

PMID:
12926071
[PubMed - indexed for MEDLINE]
9.

Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.

Christoph F, Müller M, Schostak M, Soong R, Tabiti K, Miller K.

Urology. 2004 Jul;64(1):157-61.

PMID:
15245962
[PubMed - indexed for MEDLINE]
10.

Detection of newly diagnosed bladder cancer, bladder cancer recurrence and bladder cancer in patients with hematuria using quantitative rt-PCR of urinary survivin.

Kenney DM, Geschwindt RD, Kary MR, Linic JM, Sardesai NY, Li ZQ.

Tumour Biol. 2007;28(2):57-62. Epub 2007 Jan 26.

PMID:
17259754
[PubMed - indexed for MEDLINE]
11.

Survivin mRNA copy number in bladder washings predicts tumor recurrence in patients with superficial urothelial cell carcinomas.

Schultz IJ, Kiemeney LA, Karthaus HF, Witjes JA, Willems JL, Swinkels DW, Gunnewiek JM, de Kok JB.

Clin Chem. 2004 Aug;50(8):1425-8. No abstract available.

PMID:
15277352
[PubMed - indexed for MEDLINE]
Free Article
12.

Overexpression of clusterin in transitional cell carcinoma of the bladder is related to disease progression and recurrence.

Miyake H, Gleave M, Kamidono S, Hara I.

Urology. 2002 Jan;59(1):150-4.

PMID:
11796313
[PubMed - indexed for MEDLINE]
13.

[Expression of Survivin in transitional cell carcinoma of urinary bladder and its clinical significance].

Xiao ZJ, Zheng S, Chen W, Zhang HF, Li CL, Gao YN.

Zhonghua Yi Xue Za Zhi. 2004 Dec 2;84(23):1977-9. Chinese.

PMID:
15730809
[PubMed - indexed for MEDLINE]
14.

Expression of survivin, a novel inhibitor of apoptosis, in superficial transitional cell carcinoma of the bladder.

Ku JH, Kwak C, Lee HS, Park HK, Lee E, Lee SE.

J Urol. 2004 Feb;171(2 Pt 1):631-5.

PMID:
14713775
[PubMed - indexed for MEDLINE]
15.

Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.

Nouraee N, Mowla SJ, Ozhand A, Parvin M, Ziaee SA, Hatefi N.

Urol J. 2009 Spring;6(2):101-8.

PMID:
19472128
[PubMed - indexed for MEDLINE]
16.

Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer.

Moussa O, Abol-Enein H, Bissada NK, Keane T, Ghoneim MA, Watson DK.

J Urol. 2006 Jun;175(6):2312-6.

PMID:
16697865
[PubMed - indexed for MEDLINE]
17.

Effect of intravesical treatment of transitional cell carcinoma with bacillus Calmette-Guerin and mitomycin C on urinary survivin levels and outcome.

Hausladen DA, Wheeler MA, Altieri DC, Colberg JW, Weiss RM.

J Urol. 2003 Jul;170(1):230-4.

PMID:
12796695
[PubMed - indexed for MEDLINE]
18.

Survivin mRNA expression in urine as a biomarker for patients with transitional cell carcinoma of bladder.

Hou JQ, He J, Wen DG, Chen ZX, Zeng J.

Chin Med J (Engl). 2006 Jul 5;119(13):1118-20. No abstract available.

PMID:
16834932
[PubMed - indexed for MEDLINE]
19.

Clinical experience with survivin as a biomarker for urothelial bladder cancer.

Horstmann M, Bontrup H, Hennenlotter J, Taeger D, Weber A, Pesch B, Feil G, Patschan O, Johnen G, Stenzl A, Brüning T.

World J Urol. 2010 Jun;28(3):399-404. doi: 10.1007/s00345-010-0538-2. Epub 2010 Mar 23.

PMID:
20309562
[PubMed - indexed for MEDLINE]
20.

Survivin and MKI67 mRNA expression in bladder washings of patients with superficial urothelial cell carcinoma correlate with tumor stage and grade but do not predict tumor recurrence.

Schultz IJ, Kiemeney LA, Willems JL, Swinkels DW, Witjes JA, de Kok JB.

Clin Chem. 2006 Jul;52(7):1440-2. No abstract available.

PMID:
16798976
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk